Katia J Bruxvoort Selected Research

Katia J Bruxvoort Research Topics

7	Infections 06/2022 - 01/2019
5	COVID-19 02/2022 - 12/2021
4	Malaria 01/2020 - 03/2017
2	Herpes Zoster 03/2022 - 01/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2022
1	Pneumonia (Pneumonitis) 09/2022
1	Gonorrhea 06/2022
1	Hepatitis D 12/2021
1	Human Influenza (Influenza) 01/2019
1	Pain (Aches) 01/2019
1	Fever (Fevers) 10/2017
1	Carcinoma (Carcinomatosis) 03/2007
1	Prostatic Neoplasms (Prostate Cancer) 03/2007
1	Carcinogenesis 03/2007
1	Neoplasms (Cancer) 03/2007

9	VaccinesIBA 09/2022 - 01/2019
4	Anti-Bacterial Agents (Antibiotics)IBA 06/2022 - 03/2017
4	2019-nCoV Vaccine mRNA-1273IBA 02/2022 - 12/2021
3	Conjugate VaccinesIBA 09/2022 - 01/2022
3	Herpes Zoster VaccineIBA 03/2022 - 01/2019
3	Antimalarials (Antimalarial Agents)IBA 01/2020 - 03/2017
2	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 09/2022 - 01/2022
2	artemisinin (artemisinine)IBA 01/2020 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2007
1	13-valent pneumococcal vaccineIBA 09/2022
1	MenACWYIBA 06/2022
1	Polysaccharides (Glycans)IBA 06/2022
1	23-valent pneumococcal capsular polysaccharide vaccineIBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2019
1	Ribosomal DNA (rDNA)IBA 01/2019
1	Histidine (L-Histidine)FDA Link 01/2019
1	TetracyclinesIBA 03/2017
1	Metronidazole (Metric)FDA LinkGeneric 03/2017
1	Penicillins (Penicillin)FDA Link 03/2017
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 03/2017
1	AndrogensIBA 03/2007
1	probasinIBA 03/2007
1	beta CateninIBA 03/2007